Home › NDC Lookup › RxCUI directory › RxCUI 2669665

Bosutinib 50 MG Oral Capsule — RxCUI 2669665

RxNorm drug concept · Semantic clinical drug
RxCUI 2669665 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2669665
Official nameBosutinib 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)1,739 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bosutinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You have a type of leukemia called Ph+ CML, which is driven by a faulty protein in your blood cells called BCR-ABL. Think of it like a stuck 'on' switch that keeps telling those ce...
  • What exactly is bosutinib treating in my body?
  • Yes — this is actually pretty important. Food significantly increases how much of the medicine your body absorbs, so taking it on an empty stomach means you'd be getting much less...
  • Do I have to take it with food every single time?
📖 Read our full Bosutinib guide →

🕸️ Concept Web — How Bosutinib 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bosutinib 50 MG Oral Capsule RxCUI 2669665

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Bosutinib 1307619
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Bosulif 1307625
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bosutinib Oral Capsule 2669662
    • Bosutinib Oral Product 1307621
    • Bosutinib Pill 1307622
    • Bosutinib Oral Capsule [Bosulif] 2672325
    • Bosulif Oral Product 1307628
    • Bosulif Pill 1307629
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bosutinib 50 MG SCDC · 2669664
  • Bosutinib Oral Capsule SCDF · 2669662
  • Bosutinib Oral Product SCDG · 1307621
  • Bosutinib Pill SCDG · 1307622

Brand-Name Concepts

  • Bosutinib 50 MG Oral Capsule [Bosulif] SBD · 2672328
  • Bosutinib 50 MG [Bosulif] SBDC · 2672327
  • Bosutinib Oral Capsule [Bosulif] SBDF · 2672325
  • Bosulif Oral Product SBDG · 1307628
  • Bosulif Pill SBDG · 1307629
  • Bosulif BN · 1307625

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2669665 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0135-01 120 TABLET, FILM COATED in 1 BOTTLE (0069-0135-01) BOSULIF Pfizer Laboratories Div Pfizer Inc 2012-09-04
00069-0136-01 30 TABLET, FILM COATED in 1 BOTTLE (0069-0136-01) BOSULIF Pfizer Laboratories Div Pfizer Inc 2012-09-04
00069-0193-01 30 TABLET, FILM COATED in 1 BOTTLE (0069-0193-01) BOSULIF Pfizer Laboratories Div Pfizer Inc 2017-12-18
00069-0504-30 30 CAPSULE in 1 BOTTLE (0069-0504-30) BOSULIF Pfizer Laboratories Div Pfizer Inc 2024-01-02
00069-1014-15 150 CAPSULE in 1 BOTTLE (0069-1014-15) BOSULIF Pfizer Laboratories Div Pfizer Inc 2024-01-02
Observed labelers: Pfizer Laboratories Div Pfizer Inc (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.